AB-1001

· Asklepios BioPharmaceutical, Inc. (AskBio)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AB-1001, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease [Phase 1, Phase 2]

See pricing